News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Sports dominate prediction markets, but don’t bet on that being the whole story
Less than two years ago, the biggest controversy surrounding prediction markets was their enabling of speculation on elections. Then in early 2025, with…
Blog
HHS cutting Head Start red tape shows the cost of regulatory micromanagement
Individual regulations are often defended as necessary on their own terms. But as CEI Senior Fellow Wayne Crews’ Ten Thousand Commandments documents, the…
News Release
Consumers will pay the price of a trade war between US & Canada: CEI analysis
Today, Canada announced retaliatory tariffs against the US, ranging from 15 percent to 50 percent on approximately $20 billion worth of American imports.
Blog
It’s not the (government’s) thought that counts
Good intentions are not enough to create an effective regulation. An executive agency, Congress, or the White House can have the best intentions in…
Blog
Let’s end ‘reputational risk’ debanking once and for all
Although this legislative session is near its end, Congress still has the opportunity to take an important step to ensure that financial regulation is…